News
Discover the most recent news about our company
Frequent consumption of nuts, an important component of plant-based diets, is associated with a 15% reduction in total cardiovascular disease (CVD) and a 23% reduction in CVD mortality. Although small…
Improvement in the prediction of atheromatous cardiovascular disease using the Liposcale test
20 July 2021
Patients with chronic kidney disease (CKD) have a high burden of atheromatous cardiovascular disease (ASCVD) that is not fully explained by traditional lipid parameters. A study published in the clinical…
Biosfer Co-Leads a project to implement the first in vitro prognostic test for covid-19.
13 July 2021
The Agency for the Management of University and Research Grants (AGAUR) has awarded the grant for the funding of research projects PANDÈMIES 2020 to the MiL@b research group of the…
Biosfer Teslab participates in a video of covid-19 research
13 July 2021
Last week, in Biosfer Teslab, we participated in the video made as part of the URVGoals project, which shows different research being carried out at the URV with a common…
Biosfer Teslab Collaborates in Cancer Studies
13 July 2021
Metabolomics can help in the study of different cancers by analysing whether a particular type of tumour is characterised by the development of certain metabolites. To this aim, Biosfer Teslab…
Early molecular signature of Parkinson and dementia years before the diseases appear
25 May 2021
NMR metabolomics could identify altered lipoprotein and protein glycosylation profiles in REM sleep behavior disorder (iRBD), the prodromal stage of Lewy-type synucleinopathies (LTS) -including Parkinson and dementia. NMR showed predictive…
The use of Liposcale® Test in Premature Cardiovascular disease
6 April 2021
Last week, a new paper, which evaluates the use of the Liposcale® test as a predictor of premature cardiovascular disease (PRESARV-SEA Study), was published. Beyond levels of LDL-C, results reported…
Nuclear magnetic resonance-based metabolomic analysis in the assessment of preclinical atherosclerosis in type 1 diabetes and preeclampsia
2 February 2021
Dr. Amor and collaborators have published a new article in the Diabetes Research and Clinical Practice journal using our plasma metabolomics analysis. The aim of the study was to evaluate…
Biosfer Teslab’s Internacionalization
19 January 2021
Biosfer Teslab has received from the Cambra de comerç de Reus an Xpande Digital 2020: a competitive call for international digitization! This action is co-financed with FEDER funds (European Regional…